Onartuzumab Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Onartuzumab is a monoclonal antibody that blocks the binding of HGF to the MET receptor.

Clinical Use

Onartuzumab is ineffective in improving clinical outcomes in (i) combination with current first-line chemotherapy in advanced nonsquamous cell NSCLC , (ii) combination with erlotinib in previously treated stage IIIB or IV NSCLC patients (Phase III) , and (iii) combination with platinum-doublet chemotherapy in advanced squamous cell NSCLC (Phase II) .

Onartuzumab Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Onartuzumab Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
TargetMol Chemicals Inc.	+1-781-999-5354 +1-00000000000	marketing@targetmol.com	United States	32161	58
Aladdin Scientific	+1-+1(833)-552-7181	sales@aladdinsci.com	United States	57505	58
ShangHai Biochempartner Co.,Ltd	177-54423994 17754423994	2853530910@QQ.com	China	8012	62
Wuhan Chemstan Biotechnology Co., Ltd.	027-65317797 15926423062	422450190@qq.com	China	10424	58
TargetMol Chemicals Inc.	4008200310	marketing@tsbiochem.com	China	24644	58
Biolab Reagents	027-65279366 18108604862	products@biolabreagent.com	China	9818	58
Wuhan Jingkangen Biomedical Technology Co., Ltd	13720134139 13720134139	orders@jknbiochem.com	China	5821	58
Shanghai Yifei Biotechnology Co. , Ltd.	021-65675885 18964387627	customer_service@efebio.com	China	11974	58
Shanghai?Medlife?Pharm-Tech?Co.,?Ltd	021-59167510 18117107507	vip@med-life.cn	China	4997	58
Shanghai Aladdin Biochemical Technology Co.,Ltd.	+86-18521732826	market@aladdin-e.com	China	48461	58

---

• Onartuzumab
• Research Grade Onartuzumab (DHC34202)
• Onartuzumab (anti-MET)
• RG-3638|||PRO-14396|||MetMAb
• 1133766-06-9